definiens: means any and all antibodies or antibody analogue s, including Fc or Fab components thereof, derived and generated from the [COMPANY] Seque nces through the application of the [COMPANY] Platform pursuant to the Research Program . For clar ity, notwithstanding the Confidential 1 CONFIDENTAL foregoing, the Antibodies as defined hereunder shal l only include Multi - Specific Antibodies Directed t o the [COMPANY] Target Pair . ” 3 . Section 1.39 . [COMPANY] Target Pair . Section 1.39 of the Agreement is hereby deleted in its entirety and replaced with the following : means ( a ) prior to the Research Program Completio n Date, each of the following two pairs : ( 1 ) [ … * * * … ], as more specifica lly referred to [ … * * * … ], and [ … * * * … ], as more specifically referred to [ … * * * … ] ( the ) and ( 2 ) [ … * * * … ] and [ … * * * … ] ( the ; each of the [ … * * * … ] Target Pair and the [ … * * * … ] Target Pair may be referred to herein as an ) ; and ( b ) upon and after the Research Program Com pletion Date, solely the Selected Target Pair . [ … * * * … ] may each be referred to herein as . ” 4 . Section 1.67 . Interpretation . The second Subsection ( h ) in Section 1.67 of the Agreement is hereby re - lettered as Subsection ( k ) and Subs ection ( l ) is added as follows : “ and ( l ) all references to dollars or $ herein shal l be to United States Dollars, whether or not so designated . ” 5 . Section 3.1.2 . Research Term . The following sentence is hereby added at the end of Section 3.1.2 of the Agreement : “ Notwithstanding the foregoing, the Research Progra m Term for the [ … * * * … ] Target Pair shall commence on the Amendment Effective Date and conclu de twelve ( 12 ) months after the commencement of Part A – Project Initiation of the Research Plan for the [ … * * * … ] . ” 6 . Section 3.1.3(a ) . Research Plan . The following sentence is hereby added at the end of Section 3.1.3(a ) of the Agreement : “ Notwithstanding the foregoing, the [COMPANY] Sequences Directed to [ … * * * … ] shall be provided to [COMPANY] within [ … * * * … ] after the Amendment Effect i ve Date . For avoidance of any doubt, the Parties agree that the [COMPANY] Sequences Directed to [ … * * * … ] that are provided within such [ … * * * … ] period may not be the final version of such [COMPANY] S equences since the Parties acknowledge that [COMPANY] i s [ … * * * … ] such [COMPANY] Sequences by carrying out [ … * * * … ] of [ … * * * … ] and [ … * * * … ] via [ … * * * … ] and, therefore, upon [COMPANY] ’s completing this [ … * * * … ] wor k [COMPANY] will provide to [COMPANY] this [ … * * * … ] version of such [COMPANY] Sequences . ” 7 . Section 3.1.5 . Replacement of Target 2 . The following sentence is hereby added at the end of the first paragraph of Section 3.1.5 of the Agreement ( before clause ( a ) ): Confidential 2 CONFIDENTAL “ For clarity, the addition of the [ … * * * … ] Target Pa ir to the Agreement shall be deemed the first Replacement Target . Accordingly, after the Amendmen t Effective Date and until the expiration of the Target Replacement Term, [COMPANY] shall have the right to nominate [ … * * * … ] Replacement Target, which may be for either [ … * * * … ] or [ … * * * … ], in accordance with this Section 3.1.5 . ” 8 . Sections 3.7 and 3.8 . Product Selection and Additio nal Program Option . Sections 3.7 and 3.8 are hereby added to the Agreement as follows : “ 3.7 Product Selection